Clarity Pharmaceuticals Ltd has a total of 11 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2009. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are NEURAD LTD, WARNEFORD HEALTHCARE LTD and DASAN MEDICHEM CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Special acyclic compounds | |
#5 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Harris Matthew John | 5 |
#2 | Donnelly Paul Stephen | 4 |
#3 | Zia Nicholas Alan | 3 |
#4 | Lumb Sean | 3 |
#5 | Donnelly Paul | 2 |
#6 | Van Dam Ellen Marianne | 2 |
#7 | Paterson Brett | 2 |
#8 | Jeffery Charmaine Marie | 2 |
#9 | Ma Michelle Therese | 1 |
#10 | Scanlon Denis Bernard | 1 |
Publication | Filing date | Title |
---|---|---|
US2021015950A1 | Formulations and kits for radiotherapy and diagnostic imaging | |
AU2018280338A1 | Radiopharmaceuticals, radioimaging agents, and uses thereof | |
EP3534969A1 | Formulations for radiotherapy and diagnostic imaging | |
AU2012350147A1 | Cage amine ligands for metallo-radiopharmaceuticals |